Patent Assignment
Reel/Frame 036159/0256
Court Order
Recorded: 2015-07-22
Pages: 117
Assignor
TRANSAMERICA BUSINESS CREDIT CORPORATION
Executed: 2015-02-20
Assignee
DENDREON CORPORATION
1301 2ND AVENUE, SEATTLE, WASHINGTON, 98101
Covered Properties
(4)
Prostate Tumor Polynucleotide Compositions and Methods of Detection Thereof
Patent:
6,194,152 →
Application:
09/112,096 →
Cell Washing Device and Method
Patent:
6,197,579 →
Application:
09/118,326 →
Immunostimulatory Composition
Patent:
6,210,662 →
Application:
09/344,195 →
Selective Apoptosis of Neoplastic Cells by an Hla-Dr Specific Monoclonal Antibody
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Feb 18, 2015
From: GE BUSINESS CAPITAL CORPORATION FORMERLY TRANSAMERICA BUSINESS CAPITAL CORPORATION
To: DENDREON CORPORATION
Reel/Frame 035034/0539 →
Assignment of Assignor's Interest
Jul 16, 2015
From: DENDREON CORPORATION, AND ITS WHOLLY OWNED SUBSIDIARIES, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC, AND DENDREON MANUFACTORING, LLC
To: DRONE ACQUISITION SUB INC.
Reel/Frame 036126/0259 →
Change of Name
Jul 20, 2015
From: DRONE ACQUISITION SUB INC.
To: DENDREON PHARMACEUTICALS, INC.
Reel/Frame 036136/0181 →
Security Agreement
Jul 27, 2015
From: DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036190/0503 →
Change of Name
May 3, 2017
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 042389/0505 →
Release of Security Interest
Jul 5, 2017
From: BARCLAYS BANK PLC
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 043089/0288 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042389 Frame: 505. Assignor(S) Hereby Confirms the Change of Name.
Feb 14, 2018
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 046088/0882 →